ROTOP Pharmaka is a leading pharmaceutical company that manufactures cGMP compliant radiopharmaceuticals for Theranostics in the fields of nuclear medicine and molecular imaging and distributes them in over 40 countries worldwide. The ROTOP brand stands for quality and reliability. We attach great importance to proximity to our customers and optimal services for the best possible individual solutions.
We have over 20 years of experience in developing, manufacturing, licensing and distributing sterile cold kits for radiolabelled drugs and are continuously expanding the product portfolio together with our strategic partners.
Active ingredients, sterile lyophilizates and reagents are produced strictly according to the rules of current Good Manufacturing Practice (cGMP). Our comprehensive Quality Assurance unit is supervising our production, contract manufacturing and distribution.
Our Executive Team
Jens Junker
CEO
Dr. Antje Sterger
COO (Chief Operations Officer)
Dr. Eik Schiller
CSO (Chief Scientific Officer)
Head of Pharmaceutical Development
Hendrikje Heinrich
Dr. Felix Roschke
VP CDMO Services
Anja Schulze
VP Controlling, Finance & HR
Dr. Astrid Gräfe
VP Facility Development
Anne Zimmer
VP Quality Unit
Anke Burmester
VP Sales DACH-Region
Dr. Susan Hoppmann
Medical Affairs
Franziska Klein
Regulatory Affairs
Sustainability at ROTOP
For us at ROTOP patient safety is always our top priority. Furthermore, we are aware that as our company grows, our responsibility for sustainability and our environment increases. In order to meet this responsibility, we created a defined project team in early 2022 to develop a sustainability concept for ROTOP.